Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;55(10):2903-2912.
doi: 10.1128/JCM.00504-17. Epub 2017 Jul 26.

Babesia microti: from Mice to Ticks to an Increasing Number of Highly Susceptible Humans

Affiliations
Review

Babesia microti: from Mice to Ticks to an Increasing Number of Highly Susceptible Humans

Lars F Westblade et al. J Clin Microbiol. 2017 Oct.

Abstract

Babesia microti, a zoonotic intraerythrocytic parasite, is the primary etiological agent of human babesiosis in the United States. Human infections range from subclinical illness to severe disease resulting in death, with symptoms being related to host immune status. Despite advances in our understanding and management of B. microti, the incidence of infection in the United States has increased. Therefore, research focused on eradicating disease and optimizing clinical management is essential. Here we review this remarkable organism, with emphasis on the clinical, diagnostic, and therapeutic aspects of human disease.

Keywords: Babesia microti; United States; clinical significance; diagnosis; epidemiology; immunosuppression; infection; life cycle; prevention; relapse; transmission; treatment.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Life cycles of Ixodes scapularis and Babesia microti. Ixodes scapularis has a four-stage life cycle that generally lasts 2 years and includes vertebrate hosts (including rodents, deer, or humans), with each mobile tick stage having a blood meal on a different individual host. During the first year, mated adult female ticks detach from their vertebrate host to overwinter (1), and they lay eggs in the spring. Eggs hatch in the spring (2), and larvae attach to their first vertebrate host (usually small rodents or birds) (3). The six-legged larvae feed on the first host, generally in late summer, and may become infected with B. microti while taking a blood meal. Engorged larvae leave the host, overwinter, and molt into nymphs (4). In the spring of the second year, nymphs attach to a second vertebrate host (e.g., rodents, deer, or humans) (5); in the fall, they leave the second host to molt into adults and attach to a third vertebrate host (such as deer or humans) (6). Babesia microti has a two-host life cycle, including I. scapularis as the definitive host and a vertebrate intermediate host. In the tick (7), gametes ingested during a blood meal undergo sexual reproduction, leading to the eventual formation of infectious sporozoites. In the mammalian host (e.g., rodents or humans) (8), sporozoites initiate the erythrocytic cycle, resulting in the formation of trophozoites that divide asexually by budding. Subsequently, trophozoites transform into merozoites and perpetuate the erythrocytic cycle or gametes are ingested by ticks during a blood meal to initiate the sexual cycle. All mobile stages of I. scapularis may acquire B. microti parasites from infected first or second vertebrate hosts, but only nymphs and adults transmit parasites.
FIG 2
FIG 2
Photomicrographic images of Babesia and P. falciparum in thin blood films. (A) Images of Babesia showing small, pleomorphic, vacuolated rings. (B) Babesia organisms exhibiting pleomorphic rings and characteristic tetrad (“Maltese cross”) forms. (C) Extracellular forms of Babesia parasites. (D) Ring-form trophozoites of P. falciparum, for comparison, showing multiply infected RBCs, appliqué forms, and thin cytoplasm with double-chromatin dots. Original magnification for all images, ×1,000, with oil immersion.

Similar articles

Cited by

References

    1. Krause PJ, McKay K, Gadbaw J, Christianson D, Closter L, Lepore T, Telford SR III, Sikand V, Ryan R, Persing D, Radolf JD, Spielman A. 2003. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 68:431–436. - PubMed
    1. Diuk-Wasser MA, Liu Y, Steeves TK, Folsom-O'Keefe C, Dardick KR, Lepore T, Bent SJ, Usmani-Brown S, Telford SR III, Fish D, Krause PJ. 2014. Monitoring human babesiosis emergence through vector surveillance New England, USA. Emerg Infect Dis 20:225–231. doi:10.3201/eid2002.130644. - DOI - PMC - PubMed
    1. Zhou X, Xia S, Huang JL, Tambo E, Zhuge HX, Zhou XN. 2014. Human babesiosis, an emerging tick-borne disease in the People's Republic of China. Parasit Vectors 7:509. doi:10.1186/s13071-014-0509-3. - DOI - PMC - PubMed
    1. Sanchez E, Vannier E, Wormser GP, Hu LT. 2016. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA 315:1767–1777. doi:10.1001/jama.2016.2884. - DOI - PMC - PubMed
    1. Raffalli J, Wormser GP. 2016. Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis. Diagn Microbiol Infect Dis 85:231–232. doi:10.1016/j.diagmicrobio.2016.02.016. - DOI - PubMed

Substances

LinkOut - more resources